Lars Tramsen

1.1k total citations
30 papers, 834 citations indexed

About

Lars Tramsen is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Lars Tramsen has authored 30 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 17 papers in Epidemiology and 10 papers in Oncology. Recurrent topics in Lars Tramsen's work include Antifungal resistance and susceptibility (17 papers), Fungal Infections and Studies (17 papers) and Immune Cell Function and Interaction (9 papers). Lars Tramsen is often cited by papers focused on Antifungal resistance and susceptibility (17 papers), Fungal Infections and Studies (17 papers) and Immune Cell Function and Interaction (9 papers). Lars Tramsen collaborates with scholars based in Germany, France and Austria. Lars Tramsen's co-authors include Thomas Lehrnbecher, Stanislaw Schmidt, Ulrike Koehl, Thomas Klingebiel, Jean‐Paul Latgé, Sabine Huenecke, Konrad Bochennek, Mitra Hanisch, Stefanie Zimmermann and Cornelia Lass‐Flörl and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Lancet Oncology.

In The Last Decade

Lars Tramsen

30 papers receiving 829 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Tramsen Germany 18 429 383 333 207 94 30 834
Stanislaw Schmidt Germany 16 374 0.9× 338 0.9× 253 0.8× 91 0.4× 44 0.5× 30 677
R.I. Schiff United States 8 524 1.2× 465 1.2× 299 0.9× 91 0.4× 147 1.6× 19 888
Kunihisa Tsukada Japan 18 357 0.8× 507 1.3× 204 0.6× 93 0.4× 32 0.3× 56 991
Mario Delia Italy 16 246 0.6× 180 0.5× 102 0.3× 271 1.3× 189 2.0× 48 824
Christine Spalding United States 8 260 0.6× 291 0.8× 958 2.9× 148 0.7× 74 0.8× 10 1.2k
Bernard Tegtmeier United States 14 524 1.2× 354 0.9× 54 0.2× 229 1.1× 245 2.6× 35 904
Rosa Musella Argentina 21 572 1.3× 714 1.9× 767 2.3× 209 1.0× 24 0.3× 40 1.4k
Daniel Teschner Germany 14 177 0.4× 130 0.3× 223 0.7× 143 0.7× 75 0.8× 37 533
Roel P. Gazendam Netherlands 11 356 0.8× 460 1.2× 427 1.3× 38 0.2× 26 0.3× 12 774
Stanley Ress South Africa 14 397 0.9× 581 1.5× 581 1.7× 48 0.2× 35 0.4× 33 1.0k

Countries citing papers authored by Lars Tramsen

Since Specialization
Citations

This map shows the geographic impact of Lars Tramsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Tramsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Tramsen more than expected).

Fields of papers citing papers by Lars Tramsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Tramsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Tramsen. The network helps show where Lars Tramsen may publish in the future.

Co-authorship network of co-authors of Lars Tramsen

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Tramsen. A scholar is included among the top collaborators of Lars Tramsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Tramsen. Lars Tramsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tramsen, Lars, Konrad Bochennek, Monika Sparber‐Sauer, et al.. (2023). Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials. Cancers. 15(7). 2050–2050. 13 indexed citations
2.
Schmidt, Stanislaw, Lars Tramsen, & Thomas Lehrnbecher. (2017). Natural Killer Cells in Antifungal Immunity. Frontiers in Immunology. 8. 1623–1623. 56 indexed citations
3.
Schmidt, Stanislaw, Lars Tramsen, Ralf Schubert, et al.. (2017). Impact of human mesenchymal stromal cells on antifungal host response against Aspergillus fumigatus. Oncotarget. 8(56). 95495–95503. 9 indexed citations
4.
Tramsen, Lars, Emilia Salzmann‐Manrique, Konrad Bochennek, et al.. (2016). Lack of Effectiveness of Neutropenic Diet and Social Restrictions as Anti-Infective Measures in Children With Acute Myeloid Leukemia: An Analysis of the AML-BFM 2004 Trial. Journal of Clinical Oncology. 34(23). 2776–2783. 37 indexed citations
5.
Lucchini, Giovanna, Stanislaw Schmidt, Anna Schneider, et al.. (2014). Mesenchymal stromal cells in the antimicrobial host response of hematopoietic stem cell recipients with graft-versus-host disease—friends or foes?. Leukemia. 28(10). 1941–1948. 22 indexed citations
6.
Lehrnbecher, Thomas, Markus Kalkum, Jackson Champer, et al.. (2013). Immunotherapy in Invasive Fungal Infection - Focus on Invasive Aspergillosis. Current Pharmaceutical Design. 19(20). 3689–3712. 26 indexed citations
7.
Tramsen, Lars, Stanislaw Schmidt, Jean‐Paul Latgé, et al.. (2013). Clinical-scale generation of multi-specific anti-fungal T cells targeting Candida, Aspergillus and mucormycetes. Cytotherapy. 15(3). 344–351. 39 indexed citations
8.
Lehrnbecher, Thomas, Stanislaw Schmidt, Lars Tramsen, & Thomas Klingebiel. (2013). Immunotherapy of invasive fungal infection in hematopoietic stem cell transplant recipients. Frontiers in Oncology. 3. 17–17. 10 indexed citations
9.
Schmidt, Stanislaw, Lars Tramsen, Susanne Perkhofer, et al.. (2012). Characterization of the Cellular Immune Responses to Rhizopus oryzae With Potential Impact on Immunotherapeutic Strategies in Hematopoietic Stem Cell Transplantation. The Journal of Infectious Diseases. 206(1). 135–139. 25 indexed citations
10.
Schmidt, Stanislaw, Lars Tramsen, Susanne Perkhofer, et al.. (2012). Rhizopus oryzae hyphae are damaged by human natural killer (NK) cells, but suppress NK cell mediated immunity. Immunobiology. 218(7). 939–944. 60 indexed citations
11.
Bochennek, Konrad, Lars Tramsen, Minerva Becker, et al.. (2011). Liposomal amphotericin B twice weekly as antifungal prophylaxis in paediatric haematological malignancy patients. Clinical Microbiology and Infection. 17(12). 1868–1874. 43 indexed citations
12.
Tramsen, Lars, et al.. (2010). Challenges and Prospects of Adoptive Immunotherapy in Prevention and Treatment of Opportunistic Mycoses in Hematologic Transplant Recipients. Current Infectious Disease Reports. 12(6). 444–449. 4 indexed citations
13.
Schmidt, Stanislaw, Lars Tramsen, Mitra Hanisch, et al.. (2010). Human Natural Killer Cells Exhibit Direct Activity Against Aspergillus fumigatus Hyphae, But Not Against Resting Conidia. The Journal of Infectious Diseases. 203(3). 430–435. 93 indexed citations
14.
Huenecke, Sabine, Stefanie Zimmermann, Stephan Kloeß, et al.. (2010). IL-2−driven Regulation of NK Cell Receptors With Regard to the Distribution of CD16+ and CD16− Subpopulations and In Vivo Influence After Haploidentical NK Cell Infusion. Journal of Immunotherapy. 33(2). 200–210. 77 indexed citations
15.
Huenecke, Sabine, Stefanie Zimmermann, Konrad Bochennek, et al.. (2008). Age‐matched lymphocyte subpopulation reference values in childhood and adolescence: application of exponential regression analysis. European Journal Of Haematology. 80(6). 532–539. 65 indexed citations
16.
Beck, Olaf, Ulrike Koehl, Lars Tramsen, et al.. (2008). Enumeration of functionally active anti-Aspergillus T-cells in human peripheral blood. Journal of Immunological Methods. 335(1-2). 41–45. 22 indexed citations
17.
Lehrnbecher, Thomas, Ulrike Koehl, Boris Wittekindt, et al.. (2008). Changes in host defence induced by malignancies and antineoplastic treatment: implication for immunotherapeutic strategies. The Lancet Oncology. 9(3). 269–278. 32 indexed citations
18.
Tramsen, Lars, Ulrike Koehl, Torsten Tonn, et al.. (2008). Clinical-scale generation of human anti-Aspergillus T cells for adoptive immunotherapy. Bone Marrow Transplantation. 43(1). 13–19. 50 indexed citations
19.
Simon, Arne, Thomas Lehrnbecher, U. Bode, et al.. (2007). Piperacillin-tazobactam in pediatric cancer patients younger than 25 months: a retrospective multicenter survey. European Journal of Clinical Microbiology & Infectious Diseases. 26(11). 801–806. 6 indexed citations
20.
Lehrnbecher, Thomas, Olaf Beck, Ulrike Koehl, et al.. (2006). Generation and Functional Characterization of T Cells Against Candida albicans as Potential Immunotherapy after Allogeneic Stem Cell Transplantation.. Blood. 108(11). 3226–3226. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stanislaw Schmidt Breakdown of academic impact, for papers by R.I. Schiff Breakdown of academic impact, for papers by Kunihisa Tsukada Breakdown of academic impact, for papers by Mario Delia Breakdown of academic impact, for papers by Christine Spalding Breakdown of academic impact, for papers by Bernard Tegtmeier Breakdown of academic impact, for papers by Rosa Musella Breakdown of academic impact, for papers by Daniel Teschner Breakdown of academic impact, for papers by Roel P. Gazendam Breakdown of academic impact, for papers by Stanley Ress
Rankless by CCL
2026